Saturday, October 22, 2022

< + > Reimagining Alzheimer’s (Part 4): Cautious Optimism For A New Alzheimer’s Disease Treatment

Cautious optimism about the use of a new anti-amyloid fibril antibody for the treatment of early-stage Alzheimer's.

at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

< + > What's behind EHR-induced clinician burnout? And how to solve it?

When evaluating electronic health record systems to minimize documentation burden, usability is always the big challenge, says one informati...